Dataset | Source | Tissue | Cancer type level1 | Cancer type level2 | Drug type | Regimen | Timepoint | Cell type | avg_log2FC | p_val_adj |
GSE186960 | Panc1 cell line | Cell line | Pancreatic cancer | Pancreatic ductal adenocarcinoma (PDAC) | Chemotherapy | gemcitabine | NA | Malignant cells | 0.768873 | 9.95e-44 |
GSE169246_PacTissue | patients | Tumor tissue | Breast cancer | Advanced triple-negative breast cancer (TNBC) | Chemotherapy | paclitaxel | post | Mono/Macro | 0.406413 | 3.58e-11 |
GSE169246_PacTissue | patients | Tumor tissue | Breast cancer | Advanced triple-negative breast cancer (TNBC) | Chemotherapy | paclitaxel | post | cDCs | 0.944078 | 6.74e-05 |
GSE169246_PacTissue | patients | Tumor tissue | Breast cancer | Advanced triple-negative breast cancer (TNBC) | Chemotherapy | paclitaxel | pre | cDCs | 1.70394 | 6.94e-07 |
GSE169246_PacTissue | patients | Tumor tissue | Breast cancer | Advanced triple-negative breast cancer (TNBC) | Chemotherapy | paclitaxel | pre | Mono/Macro | 1.06462 | 3.17e-22 |
GSE169246_PacAteTissue | patients | Tumor tissue | Breast cancer | Advanced triple-negative breast cancer (TNBC) | Immunotherapy | atezolizumab + paclitaxel | post | Mono/Macro | 1.13432 | 4.79e-12 |
GSE169246_PacAteTissue | patients | Tumor tissue | Breast cancer | Advanced triple-negative breast cancer (TNBC) | Immunotherapy | atezolizumab + paclitaxel | pre | Mono/Macro | -0.727533 | 1.04e-34 |
GSE207422_Sin | patients | Tumor tissue | Lung cancer | EGFR/ALK mutation negative non-small cell lung cancer (NSCLC) | Immunotherapy | sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine) | post | Mono/Macro | 0.637461 | 9.68e-11 |
GSE207422_Sin | patients | Tumor tissue | Lung cancer | EGFR/ALK mutation negative non-small cell lung cancer (NSCLC) | Immunotherapy | sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine) | post | Neutrophils | 0.864138 | 1.54e-18 |
GSE161801_PI | patients | Bone marrow aspirate | Multiple myeloma | Refractory multiple myeloma (MM) | Targeted therapy | carfilzomib + dexamethasone | pre | Mono/Macro | 0.836256 | 0.00e+00 |
GSE139386 | H3122 cell line | Cell line | Lung cancer | EML4-ALK fusion-positive non-small cell lung cancer (NSCLC) | Targeted therapy | ceritinib | NA | Malignant cells | -1.83609 | 0.00e+00 |
GSE164897_VemCob | A375 cell line | Cell line | Melanoma | BRAFV600E-mutant melanoma | Targeted therapy | vemurafenib + combimetinib | NA | Malignant cells | 1.30204 | 0.00e+00 |
Gene symbol | motif | TF_highConf |
C15orf48 | metacluster_55.3 | E2F6; EGR1; NRF1; NRF1; NRF1; NRF1; NRF1; NRF1; NRF1; NRF1; NRF1; NRF1; ZBTB2; ZSCAN10 (directAnnotation). NFE2L1; NRF1; NRF1; NRF1 (inferredBy_Orthology). |
C15orf48 | transfac_pro__M04950 | EGR1 (directAnnotation). |
C15orf48 | taipale_cyt_meth__E2F2_GCGCGCGCGYW_eDBD_repr | E2F2 (directAnnotation). |
C15orf48 | taipale_tf_pairs__ERF_HES7_NNCACGTGNNNNCCGGAANN_CAP_repr | ERF; HES7 (directAnnotation). |
C15orf48 | transfac_pro__M00652 | NRF1 (directAnnotation). |
C15orf48 | taipale_tf_pairs__E2F1_HES7_RRCRCGYGYNNNNSGCGCSN_CAP_repr | E2F1; HES7 (directAnnotation). |
C15orf48 | transfac_pro__M04866 | HDAC2 (directAnnotation). |
C15orf48 | swissregulon__hs__ZBTB14 | ZBTB14 (directAnnotation). |
C15orf48 | metacluster_172.22 | E4F1 (inferredBy_Orthology). |
C15orf48 | metacluster_52.5 | HSFY1; HSFY1; HSFY1; HSFY2; HSFY2; HSFY2 (directAnnotation). |
C15orf48 | transfac_pro__M05647 | ZNF875 (directAnnotation). |
C15orf48 | metacluster_79.31 | ZNF708; ZNF708; ZNF708 (directAnnotation). |
C15orf48 | tfdimers__MD00449 | REL; YY1 (directAnnotation). |
C15orf48 | jaspar__MA0502.2 | NFYB (directAnnotation). |
C15orf48 | metacluster_144.8 | ZNF30; ZNF30 (directAnnotation). |
C15orf48 | transfac_pro__M04918 | EGR1 (directAnnotation). |
C15orf48 | metacluster_144.3 | ZNF704; ZNF704 (directAnnotation). |
C15orf48 | taipale_cyt_meth__ZNF460_NRMCGCCCCCCGN_eDBD_meth | ZNF460 (directAnnotation). |
C15orf48 | hdpi__TP73 | TP73 (directAnnotation). |
C15orf48 | transfac_pro__M06249 | ZNF616 (directAnnotation). |
C15orf48 | taipale_tf_pairs__GCM1_ETV7_NTNNNGGCGGAAGNNNTTCCNNN_CAP_repr | ETV7; GCM1 (directAnnotation). |
C15orf48 | taipale_tf_pairs__HOXB2_ELK1_TAATKRCCGGAAGNN_CAP_repr | ELK1; HOXB2 (directAnnotation). |
C15orf48 | taipale_tf_pairs__TFAP2C_MAX_TNSCCNNNGGSNNNCACGTGN_CAP_repr | MAX; TFAP2C (directAnnotation). |
C15orf48 | transfac_pro__M05711 | ZNF37A (directAnnotation). |
C15orf48 | transfac_pro__M01182 | HINFP (directAnnotation). |
C15orf48 | tfdimers__MD00075 | FOXO4; NANOG (directAnnotation). |
C15orf48 | tfdimers__MD00007 | E2F1; IRF8 (directAnnotation). |
C15orf48 | c2h2_zfs__M0385 | MTF1 (inferredBy_Orthology). |
C15orf48 | tfdimers__MD00495 | LEF1; TCF7; TCF7L1 (directAnnotation). |
C15orf48 | hocomoco__FOXJ3_HUMAN.H11MO.1.B | FOXJ3 (directAnnotation). |
C15orf48 | swissregulon__hs__SOX14 | SOX14 (directAnnotation). |
C15orf48 | homer__ATTAACACCT_Eomes | EOMES (directAnnotation). |
C15orf48 | transfac_pro__M05612 | ZNF189 (directAnnotation). |
C15orf48 | kznf__ZIM2_Imbeault2017_OM_MEME | ZIM2 (directAnnotation). |
C15orf48 | transfac_pro__M06106 | ZNF14 (directAnnotation). |
C15orf48 | jaspar__MA1532.2 | NR1D2 (directAnnotation). |
C15orf48 | transfac_pro__M06161 | ZNF117 (directAnnotation). |
C15orf48 | tfdimers__MD00545 | ETS1; SOX10 (directAnnotation). |
C15orf48 | taipale_tf_pairs__CLOCK_FIGLA_NCASSTGKNNNNNNNNNCACGTGN_CAP_repr | CLOCK; FIGLA (directAnnotation). |
C15orf48 | transfac_pro__M06723 | ZNF492 (directAnnotation). |
C15orf48 | taipale_tf_pairs__ELK1_ONECUT2_RSCGGAASNGRTCGATAN_CAP_repr | ELK1; ONECUT2 (directAnnotation). |
C15orf48 | transfac_pro__M06349 | ZNF629 (inferredBy_Orthology). |
C15orf48 | kznf__ZNF584_Imbeault2017_OM_RCADE | ZNF584 (directAnnotation). |
C15orf48 | metacluster_157.2 | ATF3; ATF3; ATF3; BACH1; BACH1; BACH1; BACH2; BACH2; BACH2; BACH2; BATF; BATF; BCL11A; FOS; FOS; FOS; FOS; FOS; FOS; FOSB; FOSL1; FOSL1; FOSL1; FOSL1; FOSL1; FOSL1; FOSL2; FOSL2; FOSL2; JDP2; JDP2; JDP2; JDP2; JDP2; JDP2; JDP2; JUN; JUN; JUN; JUN; JUN; JUNB; JUNB; JUNB; JUNB; JUNB; JUNB; JUND; JUND; JUND; JUND; JUND; JUND; JUND; JUND; JUND; MAF; MAFB; MAFF; MAFG; MAFK; NFE2; NFE2; NFE2; NFE2; NFE2; NFE2; NFE2L1; NFE2L1; NFE2L2; NFE2L3; ZNF3; ZSCAN5C (directAnnotation). FOSL1; JUN; JUN; JUN; JUNB; JUNB; JUND (inferredBy_Orthology). |
C15orf48 | tfdimers__MD00208 | IRF1; LTF (directAnnotation). |
C15orf48 | jaspar__MA1125.1 | ZNF384 (directAnnotation). |
C15orf48 | kznf__ZNF384_Schmitges2016_RCADE | ZNF384 (directAnnotation). |
C15orf48 | transfac_pro__M06072 | ZNF623 (directAnnotation). |
C15orf48 | transfac_pro__M02080 | ISL2 (directAnnotation). |
C15orf48 | jaspar__MA1684.1 | FOXN1 (inferredBy_Orthology). |
1 | "Sun X, Zhang Y, Li H, Zhou Y, Shi S, Chen Z, He X, Zhang H, Li F, Yin J, Mou M, Wang Y, Qiu Y, Zhu F. DRESIS: the first comprehensive landscape of drug resistance information. Nucleic Acids Res. 2023 Jan 6;51(D1):D1263-D1275. doi: 10.1093/nar/gkac812. PMID: 36243960; PMCID: PMC9825618." |
2 | "Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. doi: 10.1093/nar/gkx1037. PMID: 29126136; PMCID: PMC5753335." |